Indonesia Vision Care Market Size, Share & Forecast, By Product Type, Care Setting & Distribution Channel, 2026-2031

The Indonesia Vision Care Market was worth USD 397 million in 2025. The estimate covers domestic revenue from prescription eyeglasses, contact lenses and care, selected ophthalmic surgical and diagnostic products, low-vision products and basic vision-testing services. Spectacle lenses and frames remain the largest revenue pool because they address the broadest range of refractive needs and support recurring replacement. The base-year estimate is triangulated using provider and retailer activity, corrective unit demand, pricing, trade flows and the diagnosed population emerging from public screening programs.

The market is forecast to reach USD 589 million by 2031, expanding at a 6.80% CAGR during 2026-2031. Growth is expected to outpace the historical 5.10% CAGR because national screening expands case identification, chain retailers increase geographic coverage and premium products raise average revenue per corrected consumer. Volume growth remains important, but the forecast assumes value growth benefits from progressive lenses, high-index materials, photochromic and anti-reflective coatings, specialty contact lenses and digitally assisted fitting.

Profit pools will gradually shift from basic frames and standard single-vision lenses toward premium lens treatments, progressive products, specialty contact lenses and omnichannel replenishment. Prescription eyeglasses remain the largest category, but gross profit per transaction should rise as the premium lens mix increases from 28% in 2025 to 40% by 2031. Retailers with centralized laboratories and trained fitting personnel can monetize this shift more effectively than operators competing primarily on entry-level frame price.

The principal constraint is uneven access to qualified eye-care and refraction capacity outside major urban centers. Indonesia has about 3,000 ophthalmologists for a population exceeding 284 million, while its archipelagic geography raises outreach, equipment service and delivery costs. Affordability compounds the problem, especially in pediatric correction, where three in four children with refractive abnormalities are estimated to remain uncorrected. Providers therefore need task-sharing, mobile screening, referral partnerships and entry-price product architecture.

Indonesia ranks second by modeled 2025 market size among the selected peers, behind Thailand and ahead of Malaysia, the Philippines and Vietnam. Its USD 397 million market is supported by the region's largest population and a broad under-corrected demand base. Forecast growth of 6.8% is stronger than Thailand and Malaysia, although Vietnam and the Philippines may expand faster from smaller bases. Indonesia therefore offers a combination of scale and above-average growth rather than the highest growth rate alone.

Screening-led diagnosis is the strongest near-term driver because it creates identifiable consumers who can be referred into corrective products and specialist pathways. In 2025, approximately 55 million people were screened and 17% were found to have vision impairment. The 2026 target of about 140 million people materially enlarges the funnel. Commercial value will accrue to operators that integrate with schools, primary-care facilities and community programs, then convert screened individuals through affordable products, reliable prescriptions and repeat follow-up.